安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- SEC. gov | HOME
In this Form 10-K, we use the words "Insmed Incorporated" to refer to Insmed Incorporated, a Virginia corporation, and we use the words "Company," "Insmed," "Insmed Incorporated," "we," "us" and "our" to refer to Insmed Incorporated and its consolidated subsidiaries
- INSMED INCORPORATED - SEC. gov
Insmed Incorporated is a biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases and endocrine disorders within niche markets that have unmet medical needs
- SEC. gov
We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the Insmed Incorporated 2015 Incentive Plan and Insmed Incorporated Non-Qualified Stock Option Inducement Awards of our reports dated February 27, 2015, with respect to the consolidated financial statements of Insmed Incorporated and the
- insm-20241231 - SEC. gov
Unless the context otherwise indicates, references in this Annual Report on Form 10-K to “Insmed Incorporated” refer to Insmed Incorporated, a Virginia corporation, and the “Company,” “Insmed,” “we,” “us” and “our” refer to Insmed Incorporated together with its consolidated subsidiaries
- Document - SEC. gov
WHEREAS, Insmed Incorporated (the “Company”) sponsors and maintains the Insmed Incorporated Amended and Restated 2000 Stock Incentive Plan (as amended, the “2000 Plan”), the Insmed Incorporated 2013 Incentive Plan (as amended, the “2013 Plan”), the Insmed Incorporated 2015 Incentive Plan (as amended, the “2015 Plan”), the Insmed Incorporated 2017 Incentive Plan (as amended, the
- SEC. gov | HOME
THE PROXY STATEMENT AND FORM OF PROXY FOR OUR 2015 ANNUAL MEETING AND OUR ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2014, AS AMENDED BY THE FORM 10-K A FILED ON MARCH 30, 2015, ARE AVAILABLE AT: www insmed com under the heading "Investor Relations—SEC Filings "
- INSMED INCORPORATED - SEC. gov
In reliance on the reviews and discussions referred to above, the Audit Committee recommended to the Board (and the Board has approved) that the audited financial statement be included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2006, which was filed with the Securities and Exchange Commission on March 16, 2007
- Form 10-K - SEC. gov
Insmed Incorporated is a biopharmaceutical company focused on the development and commercialization of drug products for the treatment of metabolic diseases and endocrine disorders Our approach is to correct metabolic defects in the human body by replacing key regulatory molecules in a physiologically relevant fashion
|
|
|